Praxis reports positive seizure reduction results from vormatrigine trial

Go back to Praxis reports positive seizure reduction results from vormatrigine trial
(NASDAQ: PRAX) Delayed: 303.39 --0 (-0%)
Previous Close $303.39    52 Week High
Open $303.39    52 Week Low
Day High $303.39    P/E N/A 
Day Low $303.39    EPS
Volume 123